Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 100 Glioma 42 Brain Neoplasms 28 Neuroblastoma 25 Astrocytoma 18 Gliosarcoma 15 Sarcoma, Ewing 12 Rhabdomyosarcoma 12 Neoplasms 12 Recurrence 11 Medulloblastoma 11 Small Cell Lung Carcinoma 8 Sarcoma 8 Oligodendroglioma 8 Melanoma 7 Osteosarcoma 6 Ependymoma 6 Diffuse Intrinsic Pontine Glioma 6 Central Nervous System Neoplasms 4 Rhabdoid Tumor 3 Prostatic Neoplasms 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Neoplasm Metastasis 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Ganglioneuroblastoma 3 Desmoplastic Small Round Cell Tumor 3 Colorectal Neoplasms 3

Interventions

Oxaliplatin 27 Fluorouracil 23 Leucovorin 22 Cetuximab 22 Bevacizumab 21 Nivolumab 16 Capecitabine 16 Irinotecan 15 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 encorafenib 8 Folfox protocol 7 trifluridine tipiracil drug combination 6 Ipilimumab 6 Exercise 6 fludarabine 5 cemiplimab 5 Trastuzumab 5 Gemcitabine 5 Cyclophosphamide 5 Cisplatin 5 Blood Specimen Collection 5 Biopsy 5 regorafenib 4 pertuzumab 4 adagrasib 4 Trifluridine 4 Pemetrexed 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Temozolomide × 1 year × Clear all

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡